Skip to main content
. 2023 Jan 31;7(1):e001752. doi: 10.1136/bmjpo-2022-001752

Table 3.

Secondary outcomes: studies reporting number of cases identified with CDHL/SNHL in older children in each country

Country Author and year Screened (n) CDHL identified (n) % of CDHL NHL identified (n) % of SNHL Overall HL identified (n) % of HL 95% CI (LB to UP)
India Chadha et al.67 2013 15 718 NA NA NA NA 1578 10.30 9.57 to 10.52
Shekhar et al.68 2020 474 146 30.80 1 0.21 147 31.01 26.87 to 35.39
Turkey Tokgöz-Yılmaz et al.72 2013 239 25 10.46 1 0.42 26 10.88 7.23 to 15.53
Kaplama et al.79 2020 23 664 186 0.79 89 0.37 275 1.16 1.03 to 1.31
Iran TarvijEslami et al.78 2017 2284 28 1.23 8 0.35 36 1.58 1.11 to 2.18
Jalali et al.73 2020 2019 19 0.94 8 0.39 27 1.33 0.88 to 1.94
Tajikistan Skarzyński et al. 2016 143 NA NA NA NA 34 23.70 17.06 to 31.61
Jordan Alaqrabawi et al.74 2016 1649 54 3.27 36 2.18 90 5.45 4.41 to 6.61
Iraq Al-Obeidy et al.75 2019 425 28 6.59 2 0.47 30 7.06 4.81 to 9.92
China Lu et al.44 2011 21 547 285 1.32 16 0.07 301 1.39 1.24 to 1.56
Chen et al. 38 2012 28 546 344 1.21 22 0.08 366 1.29 1.15 to 1.42

CDHL, conductive hearing loss; HL, hearing loss; LB, lower bound; NA, not mentioned; NHL, neural hearing loss; SNHL, sensorineural hearing loss; UB, upper bound.